|
It was reported that the user experienced hypoglycemia while the ilet pump was paused, with cgm readings as low as 50 mg/dl and a concurrent fingerstick of 76 mg/dl, and remote review confirmed a recorded pause, no insulin delivery during the low event aside from a small dose earlier, and a data gap likely related to charging; the agent advised rechecking every 15 minutes and explained that insulin suspension occurs at the target threshold and that individual physiology can allow continued bg decline despite suspension.Symptoms included hypoglycemia without reported physical symptoms.Outcomes included self-treatment with four glucose tablets and a snack and continued home monitoring without hospitalization.Investigation included remote data review through the app and verification of pump pause status and delivery history, along with offer to escalate for internal software review.Investigation of this case revealed no evidence of insulin delivery during the event and no device alarms, consistent with expected suspend behavior, with the low glucose attributed to physiological factors rather than device malfunction.It was concluded, based on previously established findings for similar reports, that the cause was unclear.If the device is returned, a physical evaluation will be performed, and a supplemental will be submitted.
|